五十年的DIPG:看着未来的希望与希望
Umberto Tosi1, Mark Souweidane2
1Department of Neurosurgery, Weill Cornell Medicine, 525 E 68th St Box 99, New York, NY, 10021, USA.
概括
扩散内在庞丁质瘤 (DIPG) 是一种儿童脑干瘤,预后不好. 了解瘤生物学和药物输送方法的最新进展为治疗提供了新的可能性.
科学领域:
- 儿科神经瘤学 儿童神经瘤学
- 大脑瘤研究研究
- 癌症生物学 癌症生物学
背景情况:
- 扩散内在庞丁质瘤 (DIPG) 是一种具有高度攻击性的儿童脑干瘤,其预后在历史上很差.
- 外科干预通常是不可行的,因为瘤的位置在pons.
- 对DIPG生物学的理解有限,缺乏有效的疗法,导致了令人丧的生存率.
研究的目的:
- 审查目前对DIPG生物学,遗传学和表观遗传学的理解.
- 探索DIPG治疗的新型治疗目标和策略.
- 讨论治疗脑干瘤药物输送方法的进展.
主要方法:
- 关于DIPG的最新科学文献的审查.
- 对生物,遗传和表观遗传数据的分析.
- 评估新兴的治疗方法和药物输送技术.
主要成果:
- 增加DIPG组织的可用性有助于更深入地了解其分子基础.
- 根据最近的生物和遗传发现,确定新的治疗点.
- 开发创新策略,以改善药物透到大脑干.
结论:
- 尽管存在历史上的挑战,但DIPG研究的近期进展正在为改善治疗选择铺平道路.
- 以分子洞察力为基础的向疗法对治疗DIPG.有希望.
- 改进的药物输送系统对于克服血脑屏障和有效治疗脑干瘤至关重要.
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...